129 related articles for article (PubMed ID: 38368742)
1. Isolated melanoma cells in sentinel lymph node in stage IIIA melanoma correlate with a favorable prognosis similar to stage IB.
Amaral T; Nanz L; Stadler R; Berking C; Ulmer A; Forschner A; Meiwes A; Wolfsperger F; Meraz-Torres F; Chatziioannou E; Martus P; Flatz L; Garbe C; Leiter U
Eur J Cancer; 2024 Apr; 201():113912. PubMed ID: 38368742
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis.
Stassen RC; Maas CCHM; van der Veldt AAM; Lo SN; Saw RPM; Varey AHR; Scolyer RA; Long GV; Thompson JF; Rutkowski P; Keilholz U; van Akkooi ACJ; Verhoef C; van Klaveren D; Grünhagen DJ
Lancet Oncol; 2024 Apr; 25(4):509-517. PubMed ID: 38547894
[TBL] [Abstract][Full Text] [Related]
3. Histopathologic regression in patients with primary cutaneous melanoma undergoing sentinel lymph node biopsy is associated with favorable survival and, after metastasis, with improved progression-free survival on immune checkpoint inhibitor therapy: A single-institutional cohort study.
Wagner NB; Knierim SM; Luttermann F; Metzler G; Yazdi AS; Bauer J; Gassenmaier M; Forschner A; Leiter U; Amaral T; Garbe C; Eigentler TK; Forchhammer S; Flatz L
J Am Acad Dermatol; 2024 Apr; 90(4):739-748. PubMed ID: 38043594
[TBL] [Abstract][Full Text] [Related]
4. Interval Sentinel Lymph Nodes With the Use of Routine Lymphoscintigraphy in Extremity Melanoma.
West NJ; Wadhwa S; Ayars C; Philips P; Martin RCG; Scoggins CR; McMasters KM; Egger ME
J Surg Res; 2024 Jan; 293():613-617. PubMed ID: 37837816
[TBL] [Abstract][Full Text] [Related]
5. Is therapeutic lymph node dissection of value for lymph node recurrence in melanoma?
Wilson AK; Lourdault K; Ostad T; Stern S; Essner R
Am J Surg; 2024 Feb; 228():258-263. PubMed ID: 37923660
[TBL] [Abstract][Full Text] [Related]
6. Prediction of nonsentinel lymph node metastasis in acral melanoma with positive sentinel lymph nodes.
Lin X; Sun W; Ren M; Xu Y; Wang C; Yan W; Kong Y; Balch CM; Chen Y
J Surg Oncol; 2023 Dec; 128(8):1407-1415. PubMed ID: 37689989
[TBL] [Abstract][Full Text] [Related]
7. Conditional survival in patients with stage IB-IIIA melanoma undergoing sentinel node biopsy in Queensland: A longitudinal study.
Tedman AJ; Liyanage UE; Chong S; Rowe C; von Schuckmann LA; Malt M; Green AC; Smithers BM; Khosrotehrani K
Australas J Dermatol; 2023 Feb; 64(1):e34-e40. PubMed ID: 36651479
[TBL] [Abstract][Full Text] [Related]
8. Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2).
Broman KK; Hughes T; Dossett L; Sun J; Kirichenko D; Carr MJ; Sharma A; Bartlett EK; Nijhuis AAG; Thompson JF; Hieken TJ; Kottschade L; Downs J; Gyorki DE; Stahlie E; van Akkooi A; Ollila DW; Frank J; Song Y; Karakousis G; Moncrieff M; Nobes J; Vetto J; Han D; Farma JM; Deneve JL; Fleming MD; Perez MC; Lowe MC; Olofsson Bagge R; Mattsson J; Lee AY; Berman RS; Chai H; Kroon HM; Teras J; Teras RM; Farrow NE; Beasley G; Hui JYC; Been L; Kruijff S; Kim Y; Naqvi SMH; Sarnaik AA; Sondak VK; Zager JS
Cancer; 2021 Jul; 127(13):2251-2261. PubMed ID: 33826754
[TBL] [Abstract][Full Text] [Related]
9. The difficulty with measuring the largest melanoma tumour diameter in sentinel lymph nodes.
Laeijendecker AE; El Sharouni MA; Stathonikos N; Spoto CPE; van de Wiel BA; Eijken EJE; Mulder M; Mooyaart AL; Szumera-Cieckiewicz A; Mihic-Probst D; Massi D; Cook M; Koljenovic S; Alos L; van Diest PJ; van Akkooi ACJ; Blokx W
J Clin Pathol; 2024 May; 77(6):372-377. PubMed ID: 38378246
[TBL] [Abstract][Full Text] [Related]
10. Melanoma-specific survival in patients with positive sentinel lymph nodes: Relevance of sentinel tumor burden.
Satzger I; Leiter U; Gräger N; Keim U; Garbe C; Gutzmer R
Eur J Cancer; 2019 Dec; 123():83-91. PubMed ID: 31677550
[TBL] [Abstract][Full Text] [Related]
11. Clinical Outcomes and Risk Stratification of Early-Stage Melanoma Micrometastases From an International Multicenter Study: Implications for the Management of American Joint Committee on Cancer IIIA Disease.
Moncrieff MD; Lo SN; Scolyer RA; Heaton MJ; Nobes JP; Snelling AP; Carr MJ; Nessim C; Wade R; Peach AH; Kisyova R; Mason J; Wilson ED; Nolan G; Pritchard Jones R; Johansson I; Olofsson Bagge R; Wright LJ; Patel NG; Sondak VK; Thompson JF; Zager JS
J Clin Oncol; 2022 Dec; 40(34):3940-3951. PubMed ID: 35849790
[TBL] [Abstract][Full Text] [Related]
12. American Joint Committee on Cancer clinical stage as a selection criterion for sentinel lymph node biopsy in thin melanoma.
Vaquerano J; Kraybill WG; Driscoll DL; Cheney R; Kane JM
Ann Surg Oncol; 2006 Feb; 13(2):198-204. PubMed ID: 16418885
[TBL] [Abstract][Full Text] [Related]
13. Final Analysis of DeCOG-SLT Trial: No Survival Benefit for Complete Lymph Node Dissection in Patients With Melanoma With Positive Sentinel Node.
Leiter U; Stadler R; Mauch C; Hohenberger W; Brockmeyer NH; Berking C; Sunderkötter C; Kaatz M; Schatton K; Lehmann P; Vogt T; Ulrich J; Herbst R; Gehring W; Simon JC; Keim U; Verver D; Martus P; Garbe C;
J Clin Oncol; 2019 Nov; 37(32):3000-3008. PubMed ID: 31557067
[TBL] [Abstract][Full Text] [Related]
14. Sentinel Lymph Node Biopsy Positivity in Patients With Acral Lentiginous and Other Subtypes of Cutaneous Melanoma.
Cheraghlou S; Ugwu N; Girardi M
JAMA Dermatol; 2022 Jan; 158(1):51-58. PubMed ID: 34878492
[TBL] [Abstract][Full Text] [Related]
15. Stage IIIa Melanoma and Impact of Multiple Positive Lymph Nodes on Survival.
Woeste MR; McMasters KM; Egger ME
J Am Coll Surg; 2021 Apr; 232(4):517-524.e1. PubMed ID: 33316426
[TBL] [Abstract][Full Text] [Related]
16. Is the non-sentinel lymph node compartment the next site for melanoma progression from the sentinel lymph node compartment in the regional nodal basin?
Rios-Cantu A; Lu Y; Melendez-Elizondo V; Chen M; Gutierrez-Range A; Fadaki N; Thummala S; West-Coffee C; Cleaver J; Kashani-Sabet M; Leong SPL
Clin Exp Metastasis; 2017 Jun; 34(5):345-350. PubMed ID: 28699042
[TBL] [Abstract][Full Text] [Related]
17. Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial.
Leiter U; Stadler R; Mauch C; Hohenberger W; Brockmeyer N; Berking C; Sunderkötter C; Kaatz M; Schulte KW; Lehmann P; Vogt T; Ulrich J; Herbst R; Gehring W; Simon JC; Keim U; Martus P; Garbe C;
Lancet Oncol; 2016 Jun; 17(6):757-767. PubMed ID: 27161539
[TBL] [Abstract][Full Text] [Related]
18. Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection.
Eroglu Z; Broman KK; Thompson JF; Nijhuis A; Hieken TJ; Kottschade L; Farma JM; Hotz M; Deneve J; Fleming M; Bartlett EK; Sharma A; Dossett L; Hughes T; Gyorki DE; Downs J; Karakousis G; Song Y; Lee A; Berman RS; van Akkooi A; Stahlie E; Han D; Vetto J; Beasley G; Farrow NE; Hui JYC; Moncrieff M; Nobes J; Baecher K; Perez M; Lowe M; Ollila DW; Collichio FA; Bagge RO; Mattsson J; Kroon HM; Chai H; Teras J; Sun J; Carr MJ; Tandon A; Babacan NA; Kim Y; Naqvi M; Zager J; Khushalani NI
J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 36002183
[TBL] [Abstract][Full Text] [Related]
19. Staging of regional lymph nodes in melanoma: a case for including nonsentinel lymph node positivity in the American Joint Committee on Cancer staging system.
Leung AM; Morton DL; Ozao-Choy J; Hari DM; Shin-Sim M; Difronzo AL; Faries MB
JAMA Surg; 2013 Sep; 148(9):879-84. PubMed ID: 23903435
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Indications for Sentinel Node Biopsy in Early-Stage Melanoma with the Advent of Adjuvant Systemic Therapy: An International, Multicenter Study.
Moncrieff MD; Lo SN; Scolyer RA; Heaton MJ; Nobes JP; Snelling AP; Carr MJ; Nessim C; Wade R; Peach AH; Kisyova R; Mason J; Wilson ED; Nolan G; Pritchard Jones R; Sondak VK; Thompson JF; Zager JS
Ann Surg Oncol; 2022 Sep; 29(9):5937-5945. PubMed ID: 35562521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
